Davita Clinical Research (Trri)
Country not established
- Devices
- 1
What Davita Clinical Research (Trri) makes
Davita Clinical Research (Trri) manufactures the DBB-05 Hemodialysis Delivery System, a medical device designed for the administration of hemodialysis treatments. This system is intended to provide controlled delivery of dialysis fluid and monitoring capabilities for patient care during hemodialysis procedures.
The DBB-05 Hemodialysis Delivery System is classified as a Class II device under FDA regulations and is listed in the FDA’s 510(k) clearance registry. The company is based in the United States.
Catalogue
Dbb-05 Hemodialysis Delivery System Ref K023509
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Davita Clinical Research (Trri) have in the registry?
The registry currently lists 1 device for Davita Clinical Research (Trri). Devices recorded under merged duplicate company entries are counted once.
Which registries list Davita Clinical Research (Trri)'s devices?
Among its 1 most recently registered device, Davita Clinical Research (Trri) has devices listed in FDA 510(k) (1 device).
What risk classes do Davita Clinical Research (Trri)'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Davita Clinical Research (Trri)'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Davita Clinical Research (Trri) in the registry?
The most recently registered devices listed for Davita Clinical Research (Trri) include DBB-05 HEMODIALYSIS DELIVERY SYSTEM.